Nomura Holdings Inc Amgen Inc Put Options Transaction History

Nomura Holdings Inc

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $3.6 Million - $4.37 Million	13,700 New	13,700 $4.28 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $33.9 Million - $41.3 Million	150,000 New	150,000 $36.3 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $2.51 Million - $2.83 Million	13,900 Added 182.89%	21,500 $4.07 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $3.09 Million - $3.47 Million	-18,600 Reduced 70.99%	7,600 $976,000
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $10.7 Million - $12.5 Million	-63,200 Reduced 70.69%	26,200 $4.48 Million
Q1 2018 May 14, 2018	BUY	$169.43 - $198.0 $4.44 Million - $5.19 Million	26,200 Added 41.46%	89,400 $15.5 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $1.59 Million - $1.77 Million	9,400 Added 17.47%	63,200 $11 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $9 Million - $10.3 Million	53,800	53,800 $9.92 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.